157 related articles for article (PubMed ID: 24627133)
1. PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation.
Huang S; Liao Q; Li L; Xin D
Tumour Biol; 2014 Jul; 35(7):6265-70. PubMed ID: 24627133
[TBL] [Abstract][Full Text] [Related]
2. Pttg1 inhibits TGFβ signaling in breast cancer cells to promote their growth.
Zhang G; Zhao Q; Yu S; Lin R; Yi X
Tumour Biol; 2015 Jan; 36(1):199-203. PubMed ID: 25227666
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
[TBL] [Abstract][Full Text] [Related]
5. [Downregulation of PTTG1 expression inhibits the proliferation and invasiveness and promotes the apoptosis of human prostate cancer LNCaP-AI cells].
Cao XL; Wei YY; Song XM; Lu KQ; Yu WC; Chen YQ; Liu YL; Gao JP
Zhonghua Nan Ke Xue; 2017 Jul; 23(7):589-597. PubMed ID: 29723450
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.
Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L
Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516
[TBL] [Abstract][Full Text] [Related]
7. PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion.
Zhang Z; Jin B; Jin Y; Huang S; Niu X; Mao Z; Xin D
Exp Cell Res; 2017 Jan; 350(1):1-8. PubMed ID: 27756608
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1.
Castilla C; Flores ML; Medina R; Pérez-Valderrama B; Romero F; Tortolero M; Japón MA; Sáez C
Mol Cancer Ther; 2014 Oct; 13(10):2372-83. PubMed ID: 25122070
[TBL] [Abstract][Full Text] [Related]
9. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer.
Majumder S; Bhowal A; Basu S; Mukherjee P; Chatterji U; Sengupta S
J Cell Physiol; 2016 Nov; 231(11):2482-92. PubMed ID: 26919443
[TBL] [Abstract][Full Text] [Related]
10. PTTG1 knockdown enhances radiation-induced antitumour immunity in lung adenocarcinoma.
Chen Z; Cao K; Hou Y; Lu F; Li L; Wang L; Xia Y; Zhang L; Chen H; Li R; Chang L; Li W
Life Sci; 2021 Jul; 277():119594. PubMed ID: 33984357
[TBL] [Abstract][Full Text] [Related]
11. Targeting SMAD3 for inhibiting prostate cancer metastasis.
Xia Q; Li C; Bian P; Wang J; Dong S
Tumour Biol; 2014 Sep; 35(9):8537-41. PubMed ID: 25056536
[TBL] [Abstract][Full Text] [Related]
12. Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein.
Chen PY; Tien HJ; Chen SF; Horng CT; Tang HL; Jung HL; Wu MJ; Yen JH
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649138
[TBL] [Abstract][Full Text] [Related]
13. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
Noll JE; Vandyke K; Hewett DR; Mrozik KM; Bala RJ; Williams SA; Kok CH; Zannettino AC
J Hematol Oncol; 2015 Oct; 8():106. PubMed ID: 26445238
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
[TBL] [Abstract][Full Text] [Related]
15. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
16. [Down-regulated PTTG1 expression promotes the senescence of human prostate cancer LNCaP-AI].
Wei YY; Song XM; Xiong ZH; Lu KQ; Zheng L; Cao XL
Zhonghua Nan Ke Xue; 2019 Mar; 25(3):216-222. PubMed ID: 32216239
[TBL] [Abstract][Full Text] [Related]
17. [Regulation of expression of pituitary tumor transforming gene 1 (PTTG1) by androgen in prostate cancer].
Xin DQ; Zhu XH; Lai YQ; You R; Na YQ; Guo YL; Mao ZB
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):638-40. PubMed ID: 16378119
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1.
Guo XC; Li L; Gao ZH; Zhou HW; Li J; Wang QQ
Aging (Albany NY); 2019 Mar; 11(5):1333-1341. PubMed ID: 30853662
[TBL] [Abstract][Full Text] [Related]
19. Pttg1 Promotes Growth of Breast Cancer through P27 Nuclear Exclusion.
Xiea Y; Wangb R
Cell Physiol Biochem; 2016; 38(1):393-400. PubMed ID: 26824458
[TBL] [Abstract][Full Text] [Related]
20. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
